Posted inNonfiction, Quotes

How ‘Body Worlds’ Inspired People to Leave Their Bodies to Science

Von Hagens has no shortage of donors. His exhibitions have used 1,100 bodies – but he claims to have another 12,100 living donors signed up. One is Emma Knott, a PR consultant in London. “I was so inspired after I saw the exhibition], which is why I made that decision,” she says. But does she have reservations? “Not really, I mean let’s face it I’m going to be dead.” For her, the attraction lies in encouraging people to get excited about science and anatomy.

Posted inNonfiction, Quotes

What Would a More Efficient Clinical Trial System Look Like?

What might a more-efficient trial system look like? One collaboration in Chicago offers a possible way forward. Working together, several of the city’s academic medical centers have established a joint network for conducting clinical trials. Participating institutions now routinely interview all of their hospitalized patients, regardless of diagnosis, to keep detailed records on their health […]

Posted inNonfiction, Quotes

Anxiety, Depression and OCD: Inside America's Zoos

Zoos contact Virga when animals develop difficulties that vets and keepers cannot address, and he is expected to produce tangible, observable results. Often, the animals suffer from afflictions that haven’t been documented in the wild and appear uncomfortably close to our own: He has treated severely depressed snow leopards, brown bears with obsessive-compulsive disorder and […]

Posted inUncategorized

U.S. Health Care Spending for Native Americans

“It’s well-documented that the government’s attempts to meet its obligations to the Native Americans have failed miserably; the primary cause is insufficient funding. Currently, prisoners receive significantly higher per capita health-care funding than Native Americans. The U.S. Commission on Civil Rights reports the federal government spends about $5,000 per capita each year on health care […]

Posted inUncategorized

“In the jargon of economics, the demand for therapeutic drugs is ‘price inelastic’: increasing the price doesn’t reduce how much the drugs are used. Prices are set and raised according to what the market will bear, and the parties who actually pay the drug companies will meet whatever price is charged for an effective drug […]

Verify your email

We'll send a verification code to .

Gift this article